Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

The Role of Natural Killer Cells in Inflammation in Active Adult-onset Still Disease

JU-YANG JUNG and HYOUN-AH KIM
The Journal of Rheumatology October 2019, 46 (10) 1253-1255; DOI: https://doi.org/10.3899/jrheum.190369
JU-YANG JUNG
Department of Rheumatology, Ajou University Medical School;
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for JU-YANG JUNG
HYOUN-AH KIM
Department of Rheumatology, Ajou University Medical School, Suwon, Korea.
Roles: Associate Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for HYOUN-AH KIM
  • For correspondence: nakhada@naver.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Adult-onset Still disease (AOSD) is a systemic inflammatory disease characterized by spiking fever, arthralgia, rash, leukocytosis, and hepatosplenomegaly, similar to systemic-onset juvenile idiopathic arthritis (sJIA)1,2. The etiology of AOSD is unclear but the disease is thought to result from a combination of genetic and environmental factors. The disease pathology is characterized by widespread immune dysregulation, involving cytokines and their receptors, immune cells, and tissues. Activation of the innate immune system plays a major role in the systemic inflammation that characterizes AOSD and sJIA3. Activated macrophages and neutrophils induce increased levels of proinflammatory cytokines, such as interleukin (IL)-1β, IL-18, IL-6, and interferon (IFN)-γ. These proinflammatory cytokines provoke activation of macrophages and neutrophils, and differentiation of T cells. Decreased numbers and functional impairment of natural killer (NK) cells have also been implicated in the pathogenesis of AOSD and sJIA4,5.

NK cells are an important lymphocytic component of the innate immune system, providing a cytotoxicity defense against malignant, infected, and autoreactive cells6,7. NK cells exert their effects by secreting cytolytic granules such as perforin, granzyme, and serine proteases, and induce caspase-dependent apoptosis through death receptors including Fas/FasL. Impaired cytotoxic function of NK cells leads to excessive activation of macrophages and T cells, as seen in macrophage activation syndrome (MAS), and is a major, life-threatening complication of AOSD and sJIA8,9. Primary hemophagocytic lymphohistiocytosis (HLH), a hereditary disorder of MAS, occurs as a result of genetic defects in the perforin- or granzyme-dependent pathways of NK cells or cytotoxic T cells10. Additional genetic mutations associated with inhibitory or stimulatory NK cell receptors have also been observed in secondary HLH. The resulting failure of NK cells to lyse activated antigen-presenting cells results in sustained stimulation of lymphocytes and macrophages, leading to a cascade of inflammatory cytokines. Taken together, these data suggest that the dysfunction of NK cells or NK T cells may be important in the underlying systemic inflammation and macrophage activation seen in chronic inflammatory disorders, such as sJIA and AOSD. Alteration of NK cells has been well documented in AOSD and sJIA11, with active AOSD patients exhibiting decreased circulating NK T cells along with NK cells with poor proliferative function and impaired cytotoxicity4,5. Such defective NK cytotoxicity was confirmed by the impaired IL-18–induced IFN-γ production seen in patients with sJIA12. Further, downregulated NK T or NK cell populations recovered during remission of sJIA or AOSD4,13.

In this issue of The Journal, Shimojima, et al investigated the characteristics of circulating NK cells, including IFN-γ production, in patients with active AOSD14. Based on flow cytometry data, Shimojima, et al showed that the number of IFN-γ expressing NK cells was increased in acute AOSD compared to healthy controls (HC), although the proportion of circulating NK cells as a percentage of total lymphocytes was decreased. Further, expression of IL-12 and IL-15 receptors, but not of IL-18 receptors, was significantly increased on NK cells in acute AOSD. The cytotoxicity of NK cells depends on IFN-γ, with IL-18, IL-12, and IL-15 modulating the secretion of IFN-γ by interacting with their receptors on NK cells15. A defect in the phosphorylation of IL-18 receptor-β on NK cells has been reported in sJIA16, and may contribute to impaired NK cell expansion in AOSD despite the high levels of IL-18 seen in these patients. Similarly, that study also found that increased IL-18 levels were not correlated with the number of IFN-γ-expressing NK cells. The accompanying increases in IL-12 and IL-15 receptor expression on NK cells could be regarded as a compensatory reaction against high levels of intracellular IFN-γ. These data show that the persistent upregulation of IL-18 in acute AOSD does not affect NK cell expression levels, despite the higher numbers of IFN-γ–expressing NK cells in these patients.

NK cells are divided into 5 phenotypes based on differences in surface receptor expression and cytotoxic functions17. CD56dim cells exhibit more potent cytolytic activity and contain more cytoplasmic granules than CD56bright cells, which have higher proliferative potential and show enhanced cytokine production18. Shimojima, et al divided NK cells into 2 distinct subsets according to CD56 expression, and enhanced their IFN-γ–producing ability14. IFN-γ expression in CD56bright cells was significantly decreased in acute AOSD compared to HC, while IFN-γ expression in CD56dim was significantly increased. This result suggested 2 basic hypotheses: that CD56dim NK cells develop their ability to produce IFN-γ during AOSD development in response to other immunopathogenic cells, and that the absolute number of NK cells expressing IFN-γ can be altered during the transition from CD56bright to CD56dim in acute AOSD. While the lower proportion of CD56bright cells could be regarded as a paradoxical phenomenon due to their higher IFN-γ expression, this effect may be due to a lack of immunomodulating cytokines such as IL-10 and IL-13, which are induced by CD56bright cells19. Further, the lack of regulatory CD56bright NK cells might exacerbate the inflammatory response in AOSD. To confirm this hypothesis, in vitro experiments should be conducted under various conditions.

The data from Shimojima, et al revealed some limitations regarding the extent of the role of NK cells in the pathogenesis of AOSD. First, they evaluated the total number of NK cells and IFN-γ–expressing NK cells, along with IL-12, IL-15, and IL-18 receptor expression levels in each NK cell population; however, functional studies of each NK cell population were not performed. NK cells are a critical cytotoxic regulator of the immune response, with NK cell dysfunction thought to be an important factor in AOSD. A better understanding of differences in cytotoxic function based on IFN-γ production in NK cells, and of NK cell frequency, may be important for evaluating the role of these cells in AOSD pathogenesis. Second, the study evaluated only the association between NK cell characteristics and acute inflammation in AOSD. Recently, AOSD was shown to exhibit 2 distinct patterns of disease progression: systemic inflammatory and chronic articular patterns2. The systemic inflammatory pattern is characterized by recurrent systemic flares, such as fever, rash, and myalgia, while the chronic articular pattern is characterized by persistent symptoms of erosive arthritis, similar to rheumatoid arthritis3. Many researchers have suggested that NK cell dysfunction could be related to systemic inflammation, rather than the chronic articular pattern of AOSD pathogenesis2. However, in the cited study14, patients experiencing AOSD flares during followup were not included, and the patterns of AOSD were not described. Third, Shimojima, et al showed that circulating NK cell counts were negatively correlated with AOSD activity when comparing active and remission status; however, the authors did not consider the influence of treatment, particularly with glucocorticoids. Glucocorticoids were shown to suppress initial release of IFN-γ from NK cells, and to enhance cell proliferation and survival in the presence of IL-2 and IL-1220. Considering that glucocorticoids are the treatment of choice in AOSD, changes in the population or function of NK cells might be affected by administration of these agents. Intriguingly, the levels of IFN-γ–producing NK cells were decreased after remission in almost all patients with AOSD, with 4 of 7 patients in remission currently receiving glucocorticoids as a maintenance therapy. Therefore, to rule out an effect of glucocorticoids, greater numbers of followup patients in remission not treated with corticosteroids should be recruited, to confirm the number of IFN-γ–producing NK cells in AOSD remission14. Although Shimojima, et al suggested a possible connection between changes in the levels of cytokines (such as IL-18) and NK cell characteristics, they failed to demonstrate a clear linkage mechanism because of the absence of in vitro functional studies. Finally, the number of subjects in their study was small, and peripheral blood cells in patients with remission status could be affected by a variety of factors, such as the types of drugs administered.

Several analyses revealed impaired NK cell cytotoxicity and decreased NK cell number in acute AOSD (Table 1); however, the cause of impaired NK cell cytotoxicity and decreased NK cell numbers remains unclear. Evidence regarding the underlying cause of such changes in NK cells, both in patients with active AOSD and those in remission, and of the associations between cytokine levels and NK cell cytotoxicity in AOSD and sJIA, is sorely lacking. Possible causes of these phenomena include pathologic alterations, including the release of lower levels of IFN-γ from NK cells, as well as effects of genetic susceptibilities on NK cell function; however, data on the effects of genetic factors on NK cell cytotoxicity in sJIA and AOSD remain scarce.

View this table:
  • View inline
  • View popup
Table 1.

Current findings regarding the role of natural killer cells in adult-onset Still disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA).

The NK cell machinery includes a variety of receptors with both inhibitory and excitatory actions, which together control NK cell activation. A study examining gene expression in patients with AOSD identified a specific gene polymorphism in NK cell receptors13. Similarly, an in vitro assay examining killer cell immunoglobulin-like receptors (KIR), which are composed of inhibitory and excitatory receptors, revealed lower levels of the excitatory receptor KIR2DS4 in sJIA compared to polyarticular and pauciarticular JIA. While such genetic differences may lead to uncontrolled innate immune activation, more conclusive evidence regarding the genetic susceptibility of NK cells in AOSD is required.

A better understanding of the role of NK cells in the pathogenesis of AOSD is necessary for proper diagnosis and treatment of patients with AOSD. Despite certain limitations in the data, this study has improved our understanding of NK cell characteristics and IFN-γ production patterns in AOSD14. The data presented in this article help to clarify the details regarding IFN-γ production according to the expression of various receptors and NK cell subsets in AOSD. However, it remains unclear whether the observed changes in NK cells are associated with disease etiology or arise as a result of the chronic immune dysregulation seen in this disease. Ongoing genetic and molecular investigations into these various aspects of AOSD pathology may help to explain the changes in NK cells seen therein, and their roles in disease pathogenesis.

Footnotes

  • See NK cells in AOSD, page 1268

  • This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (grant number 2019R1A2C1005988).

REFERENCES

  1. 1.↵
    1. Giacomelli R,
    2. Ruscitti P,
    3. Shoenfeld Y
    . A comprehensive review on adult onset Still’s disease. J Autoimmun 2018;93:24–36.
    OpenUrl
  2. 2.↵
    1. Gerfaud-Valentin M,
    2. Jamilloux Y,
    3. Iwaz J,
    4. Seve P
    . Adult-onset Still’s disease. Autoimmun Rev 2014;13:708–22.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ruscitti P,
    2. Giacomelli R
    . Pathogenesis of adult onset Still’s disease: current understanding and new insights. Expert Rev Clin Immunol 2018;14:965–76.
    OpenUrl
  4. 4.↵
    1. Lee SJ,
    2. Cho YN,
    3. Kim TJ,
    4. Park SC,
    5. Park DJ,
    6. Jin HM,
    7. et al.
    Natural killer T cell deficiency in active adult-onset Still’s Disease: correlation of deficiency of natural killer T cells with dysfunction of natural killer cells. Arthritis Rheum 2012;64:2868–77.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Park JH,
    2. Kim HS,
    3. Lee JS,
    4. Kim JJ,
    5. Jung KH,
    6. Park YW,
    7. et al.
    Natural killer cell cytolytic function in Korean patients with adult-onset Still’s disease. J Rheumatol 2012;39:2000–7.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Popko K,
    2. Gorska E
    . The role of natural killer cells in pathogenesis of autoimmune diseases. Cent Eur J Immunol 2015;40:470–6.
    OpenUrl
  7. 7.↵
    1. Caligiuri MA
    . Human natural killer cells. Blood 2008;112:461–9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Cifaldi L,
    2. Prencipe G,
    3. Caiello I,
    4. Bracaglia C,
    5. Locatelli F,
    6. De Benedetti F,
    7. et al.
    Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol 2015;67:3037–46.
    OpenUrl
  9. 9.↵
    1. Villanueva J,
    2. Lee S,
    3. Giannini EH,
    4. Graham TB,
    5. Passo MH,
    6. Filipovich A,
    7. et al.
    Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res 2005;7:R30–7.
    OpenUrl
  10. 10.↵
    1. Filipovich AH,
    2. Chandrakasan S
    . Pathogenesis of hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 2015;29:895–902.
    OpenUrl
  11. 11.↵
    1. Avau A,
    2. Put K,
    3. Wouters CH,
    4. Matthys P
    . Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine Growth Factor Rev 2015;26:35–45.
    OpenUrl
  12. 12.↵
    1. Put K,
    2. Vandenhaute J,
    3. Avau A,
    4. van Nieuwenhuijze A,
    5. Brisse E,
    6. Dierckx T,
    7. et al.
    Inflammatory gene expression profile and defective interferon-gamma and granzyme K in natural killer cells from systemic juvenile idiopathic arthritis patients. Arthritis Rheumatol 2017;69:213–24.
    OpenUrl
  13. 13.↵
    1. Zhou J,
    2. Tang X,
    3. Ding Y,
    4. An Y,
    5. Zhao X
    . Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. Pediatr Allergy Immunol 2013;24:691–6.
    OpenUrl
  14. 14.↵
    1. Shimojima Y,
    2. Kishida D,
    3. Ueno KI,
    4. Ushiyama S,
    5. Ichikawa T,
    6. Sekijima Y
    . Characteristics of circulating natural killer cells and their interferon-γ production in active adult-onset Still disease. J Rheumatol 2019;46:1268–76.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Berrien-Elliott MM,
    2. Wagner JA,
    3. Fehniger TA
    . Human cytokine-induced memory-like natural killer cells. J Innate Immun 2015;7:563–71.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. de Jager W,
    2. Vastert SJ,
    3. Beekman JM,
    4. Wulffraat NM,
    5. Kuis W,
    6. Coffer PJ,
    7. et al.
    Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2782–93.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Zhang C,
    2. Tian Z
    . NK cell subsets in autoimmune diseases. J Autoimmun 2017;83:22–30.
    OpenUrl
  18. 18.↵
    1. Moretta L
    . Dissecting CD56dim human NK cells. Blood 2010;116:3689–91.
    OpenUrlFREE Full Text
  19. 19.↵
    1. Wilk E,
    2. Kalippke K,
    3. Buyny S,
    4. Schmidt RE,
    5. Jacobs R
    . New aspects of NK cell subset identification and inference of NK cells’ regulatory capacity by assessing functional and genomic profiles. Immunobiol 2008;213:271–83.
    OpenUrlPubMed
  20. 20.↵
    1. Morgan DJ,
    2. Davis DM
    . Distinct effects of dexamethasone on human natural killer cell responses dependent on cytokines. Front Immunol 2017;8:432.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Takakura M,
    2. Shimizu M,
    3. Yakoyama T,
    4. Mizuta M,
    5. Yachie A
    . Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis. Pediatr Int 2018;60:984–5.
    OpenUrl
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 10
1 Oct 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Natural Killer Cells in Inflammation in Active Adult-onset Still Disease
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Role of Natural Killer Cells in Inflammation in Active Adult-onset Still Disease
JU-YANG JUNG, HYOUN-AH KIM
The Journal of Rheumatology Oct 2019, 46 (10) 1253-1255; DOI: 10.3899/jrheum.190369

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Role of Natural Killer Cells in Inflammation in Active Adult-onset Still Disease
JU-YANG JUNG, HYOUN-AH KIM
The Journal of Rheumatology Oct 2019, 46 (10) 1253-1255; DOI: 10.3899/jrheum.190369
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • New Advances in the Knowledge of Elemental Enthesis Lesions: Doppler, Erosion, and Thickness
  • Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention
  • Celebrating The Journal of Rheumatology’s 50th Year of Publication
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire